Preparing for screening

What to gather before a trial screening visit

A plain-language guide for patients and caregivers. This page does not screen you for the trial and is not medical advice - only the trial investigators can decide eligibility after a formal screening visit.

Read this first. Eligibility for the CCI-001 Phase 1 trial (NCT04823897) is determined only by the trial investigators after a screening visit. Nothing on this page tells you whether you qualify.

Do not stop, change, or delay any current treatment based on what you read here. Talk with your treating physician about any changes.

What to prepare

Bringing these to a screening visit (or having them ready when the trial team contacts you) helps the conversation move faster. You don't need to send any of it through this website.

Recent medical records

A summary from your oncologist covering your diagnosis, pathology report, and any imaging (CT, MRI, PET) from the last 6 months.

Treatment history

A list of prior cancer treatments - surgery, radiation, chemotherapy, immunotherapy, or other trials - with approximate dates and how you responded.

Current medications

All prescriptions, over-the-counter drugs, vitamins, and supplements you take, including doses and how often.

Other health conditions

A short list of other conditions (heart, kidney, liver, autoimmune, etc.) and any allergies. The trial team needs this to assess safety.

Care team contacts

Name and contact info for your treating oncologist and primary care provider, so the trial team can coordinate if you ask them to.

Practical logistics

Think about travel, time off work, and who could come with you. Screening usually involves more than one visit over a few weeks.

What to expect

  1. 1. Initial contact

    A trial coordinator reaches out to discuss the study, answer questions, and outline the next steps. No medical decisions are made at this stage.

  2. 2. Informed consent

    Before any screening tests, you'll review and sign an informed consent document that explains the study, possible risks, and your rights. You can withdraw at any time.

  3. 3. Screening visit

    Investigators review your medical history and run tests required by the protocol (bloodwork, imaging, etc.) to confirm eligibility.

  4. 4. Eligibility decision

    The trial team tells you whether you're eligible. If not, they'll explain why and, where possible, point you to other options.

Questions to ask the trial team

  • What does the screening visit involve, and how long will it take?
  • What tests will I need, and are any of them invasive?
  • How is the study drug given, and how often?
  • What are the known side effects so far?
  • What happens if I'm not eligible after screening?
  • Are travel, lodging, or other costs covered?
  • Who do I contact between visits if something comes up?

Important reminders

  • This page is educational. It is not medical advice and does not determine trial eligibility.
  • Please don't send detailed medical records, lab values, or images through our website. Share those only with the trial team during a formal screening visit.
  • If your situation is urgent, contact your local emergency services or your treating physician.